Factors, enablers and challenges for COVID-19 vaccine development
The COVID-19 pandemic triggered a sense of vulnerability and urgency that led to concerted actions by governments, funders, regulators and industry to overcome traditional challenges for the development of vaccine candidates and to reach authorisation. Unprecedented financial investments, massive de...
Main Authors: | Peter J Hotez, Lois Privor-Dumm, Melanie Saville, Jerome H Kim, Sarah Gilbert, Salim Abdool-Karim, Didi Thompson, Jean-Louis Excler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-06-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/8/6/e011879.full |
Similar Items
-
COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats
by: Peter J Hotez, et al.
Published: (2023-06-01) -
Vaccine access, equity and justice: COVID-19 vaccines and vaccination
by: Peter J Hotez, et al.
Published: (2023-06-01) -
Determinants of policy and uptake of national vaccine programs for pregnant women: results of mixed method study from Spain, Italy, and India
by: Lois Privor-Dumm
Published: (2021-05-01) -
Nonstructural barriers to adult vaccination
by: T. Mark Doherty, et al.
Published: (2024-12-01) -
Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges
by: Heeyoun Cho, et al.
Published: (2018-02-01)